Recomienda este artículo a tus amigos:
Pharma M&A versus alliances and its underlying value drivers: Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective - Corporate Finance and Governance Heiko Schoen New edition
Pharma M&A versus alliances and its underlying value drivers: Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective - Corporate Finance and Governance
Heiko Schoen
This study analyzes 229 M&A and 120 in-licensing deals in the pharmaceutical industry. The author shows from a capital market perspective that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. Significant determinants of success for both strategies are derived.
201 pages
| Medios de comunicación | Libros Hardcover Book (Libro con lomo y cubierta duros) |
| Publicado | 28 de septiembre de 2015 |
| ISBN13 | 9783631663813 |
| Editores | Peter Lang AG |
| Páginas | 201 |
| Dimensiones | 215 × 154 × 17 mm · 362 g |
| Lengua | Francés |